MDS Latest News
Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? The innovative drug Imetelstat has been trialed on patients with lower-risk MDS who are RBC (Red Blood Cells) transfusion dependent and have experienced relapse or not been helped by erythropoiesis-stimulating agent (ESA). This group of patients does not […]
Read full story
Shielding guidance update from NHS England. See below the latests advice to patients: NHS Cancer Programme – Shielding Update 04/11/2020 Message from NHS England: The Prime Minister announced on 31 October that from 5 November to 2 December new national restrictions in England would be enacted. The government have today (4/11/20) published specific guidance for […]
Read full story
Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? A new clinical trial for MDS has just been launched. Designed by clinical experts, using existing (repurposed) drugs in a new way, with wide PPI (Patient and Public Involvement) input and feedback by MDS UK advocates and patients, […]
Read full story
Please help us support more patients! Donate on MDS UK JustGiving Page
Read full story
It’s time to get your pens, brushes and camera out for MDS WAD on Sunday October 25th! This is a crucial day for the worldwide MDS community to make a stand against this rare blood cancer and raise much needed awareness! We would like to encourage as many people from MDS UK as possible to […]
Read full story
MDS UK has teamed up with the NCRI MDS subgroup (National Cancer Research Institute), the UK MDS Forum (National MDS clinical experts group), and created a survey for MDS, CMML and AML patients and caregivers. This national survey is about your perspective and experience of the COVID-19 pandemic generally the clinical care and support you […]
Read full story
Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? The best way to study a typical group of MDS patients is to set up a registry. A registry involves obtaining consent from patients and collect information about their MDS and the treatments they receive at their usual […]
Read full story
Welcome to our “#20for20 Charity Shop”. This is the place where our amazing #20for20 fundraisers are swapping things for donations! What an excellent way to support MDS UK! How does it work? To Donate: Take a look at the available items below and decide what you’d like to swap. More items will be added in […]
Read full story
Welcome to MDS UK’s #20for20 gallery! Here, you can have a look at what some of our wonderful participants have been up to in the campaign. Whether it be running, litter-picking, hula-hooping or poetry, our #20for20 fundraisers are doing amazingly well! We hope this page inspires more people to join MDS UK in the #20for20 campaign or […]
Read full story
Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? TP53 gene mutations or chromosome 17 loss which results in TP53 deletion is present in up to 20% of MDS patients. Therapies for these patients have been relatively unsuccessful in delaying the progression of the disease. Emerging treatments […]
Read full story